Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Apexigen Raises $73m In Series B And Series C Financings
Venture Capital

Apexigen Raises $73m In Series B And Series C Financings

by prnewswire.com posted 4months ago 43 views
SAN CARLOS, Calif., Aug. 8, 2018 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the successful completion of its Series B and Series C financings in which it raised a total of $73 million. The $15 million Series B financing was led by Decheng...

In this article